ZAMPIERI, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 8.097
EU - Europa 5.168
AS - Asia 4.378
SA - Sud America 473
Continente sconosciuto - Info sul continente non disponibili 458
AF - Africa 107
OC - Oceania 4
Totale 18.685
Nazione #
US - Stati Uniti d'America 7.986
IT - Italia 1.953
SG - Singapore 1.482
CN - Cina 1.131
SE - Svezia 908
UA - Ucraina 547
VN - Vietnam 397
HK - Hong Kong 394
BR - Brasile 376
KR - Corea 343
PL - Polonia 273
FR - Francia 267
DE - Germania 238
FI - Finlandia 233
TR - Turchia 231
GB - Regno Unito 171
RU - Federazione Russa 157
IE - Irlanda 107
BG - Bulgaria 105
IN - India 85
NL - Olanda 71
BD - Bangladesh 63
CA - Canada 55
AR - Argentina 36
MA - Marocco 34
JP - Giappone 33
MY - Malesia 31
SA - Arabia Saudita 30
BE - Belgio 29
MX - Messico 27
ZA - Sudafrica 25
CH - Svizzera 20
SN - Senegal 19
ES - Italia 18
EU - Europa 18
EC - Ecuador 17
IQ - Iraq 17
AT - Austria 16
ID - Indonesia 14
IR - Iran 14
PK - Pakistan 14
CO - Colombia 11
PH - Filippine 11
CL - Cile 9
IL - Israele 9
PY - Paraguay 9
TW - Taiwan 9
AZ - Azerbaigian 8
NP - Nepal 8
RO - Romania 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
EG - Egitto 6
UY - Uruguay 6
DK - Danimarca 5
GR - Grecia 5
HR - Croazia 5
KE - Kenya 5
KZ - Kazakistan 5
OM - Oman 5
JO - Giordania 4
KG - Kirghizistan 4
LT - Lituania 4
LV - Lettonia 4
PA - Panama 4
PE - Perù 4
PS - Palestinian Territory 4
RS - Serbia 4
SV - El Salvador 4
TH - Thailandia 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AL - Albania 3
BH - Bahrain 3
CR - Costa Rica 3
ET - Etiopia 3
GT - Guatemala 3
PR - Porto Rico 3
VE - Venezuela 3
AM - Armenia 2
AO - Angola 2
AU - Australia 2
BO - Bolivia 2
DZ - Algeria 2
HN - Honduras 2
JM - Giamaica 2
MK - Macedonia 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
GE - Georgia 1
GN - Guinea 1
HU - Ungheria 1
Totale 18.231
Città #
Singapore 899
Woodbridge 854
Ann Arbor 804
Ashburn 684
Trieste 607
Chandler 511
Houston 487
Jacksonville 480
San Jose 449
Fairfield 406
Hong Kong 383
Seoul 334
Hefei 305
Beijing 300
Wilmington 287
Izmir 203
Princeton 189
Warsaw 175
Dallas 173
Boardman 165
Seattle 164
Dearborn 145
Milan 131
Ho Chi Minh City 130
Chicago 126
Columbus 124
Cambridge 120
Los Angeles 119
Dublin 106
Sofia 104
Lauterbourg 97
Zgierz 90
Rome 86
Hanoi 85
Buffalo 71
Helsinki 69
Council Bluffs 67
Moscow 66
The Dalles 66
Santa Clara 61
New York 58
Frankfurt am Main 42
São Paulo 35
Bremen 32
Naples 32
Grafing 30
Nanjing 30
Brussels 29
San Diego 29
Des Moines 27
Düsseldorf 27
Kunming 27
Casablanca 26
Tokyo 26
Catania 25
Munich 25
Da Nang 23
Messina 23
Shanghai 23
London 22
Turin 22
Phoenix 21
Redwood City 21
Verona 21
Orem 20
Chennai 19
Dakar 19
Norwalk 19
Washington 19
Guangzhou 18
Toronto 18
Jinan 17
Florence 16
Atlanta 15
Cagliari 15
Dammam 15
Montreal 15
Brooklyn 14
Mestre 14
Tianjin 14
Bern 13
Falls Church 13
Haiphong 13
Johannesburg 13
Rio de Janeiro 13
Brescia 12
Denver 12
Falkenstein 12
New Delhi 12
Perugia 12
Zhengzhou 12
Bologna 11
Nanchang 11
Portsmouth 11
Vienna 11
Bari 10
Hải Dương 10
Manchester 10
Quito 10
Shenyang 10
Totale 11.896
Nome #
Manuale di analisi qualitativa. Con e-book 696
Analisi Farmaceutica Qualitativa 516
Antimycobacterial activity of new 1,4-Benzoxazine-2-one derivatives and its 2-(arylamino)-4-oxobut-2-enoate, ring-open analogues. 346
Antimycobacterial activity of new 3,5-disubstituted 1,3,4-oxadiazol-2(3H)-one derivatives. Molecular modeling investigations 320
A 3D-Pharmacophore Model for σ2 Receptors Based on a Series of Substituted Benzo[d]oxazol-2(3H)-one Derivatives 311
Improving selectivity preserving affinity: New piperidine-4-carboxamide derivatives as effective sigma-1-ligands 296
Stability of a novel Lidocaine, Adrenaline and Tetracaine sterile thermosensitive gel: A ready-to-use formulation 289
Antimycobacterial activity of new N1-[1-[1-aryl-3-[4-(1H-imidazol-1-yl)phenyl]-3-oxo]propyl]-pyridine-2-carboxamidrazone derivatives 285
Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach 269
Antifungal and antimycobacterial activity of 1-(3,5-diaryl-4,5-dihydro-1H-pyrazol-4-yl)-1H-imidazole derivatives. 264
Antifungal and antimycobacterial activity of new N1-[1-aryl-2-(1H-imidazol-1-yl and 1H-1,2,4-triazol-1-yl)-ethylidene]-pyridine-2-carboxamidrazone derivatives: a combined experimental and computational approach 262
Computer-assisted design, synthesis, binding and cytotoxicity assessments of new 1-(4-(aryl(methyl)amino)butyl)-heterocyclic sigma 1 ligands 262
Discovery of new potent dual sigma receptor/GluN2b ligands with antioxidant property as neuroprotective agents 257
Design, synthesis and antimycobacterial activity of benzoxazinone derivatives and open-ring analogues: preliminary data and computational analysis 253
Synthesis and receptor binding studies of some new arylcarboxamide derivatives as sigma-1 ligands 251
Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the σ1 binding site 250
Imidazole and 1,2,4-Triazole-based Derivatives Gifted with Antitubercular Activity: Cytotoxicity and Computational Assessment 240
New piperidine-based derivatives as sigma receptor ligands. Synthesis and pharmacological evaluation 238
Another Brick in the Wall. Validation of the σ1Receptor 3D Model by Computer-Assisted Design, Synthesis, and Activity of New σ1Ligands 235
Synthesis, Cytotoxicity Evaluation, and Computational Insights of Novel 1,4-Diazepane-Based Sigma Ligands 226
Synthesis, biological evaluation, and three-dimensional in silico pharmacophore model for sigma1 receptor ligand based on a series of benzo[d]oxazol-2(3H)-one derivatives 221
Antimycobacterial activities of N1-[1-[3-aryl-1-(pyridin-2-,3-, or 4-yl)-3-oxo]propyl]-2-pyridinecarboxamidrazones. 210
Synthesis and antimycobacterial activity of [5-(pyridin-2-yl)-1,3,4-thiadiazol-2-ylthio]acetic acid arylidene-hydrazide derivatives 205
Homology Model and Docking-Based Virtual Screening for Ligands of the σ1 Receptor 199
Synthesis, antifungal and antimycobacterial activities of new bis-imidazole derivatives, and prediction of their binding to P45014DM by molecular docking and MM/PBSA method 196
Antimycobacterial activity of new 3-substituted 5-(pyridin-4-yl)-3H-1,3,4-oxadiazol-2-one and 2-thione derivatives. Preliminary molecular modelling investigations 192
Synthesis and antifungal activity of (9/)-1-(5-aryl-3-pyridin-2-yl-4,5-dihydro-pyrazol-1-yl)-2-imidazol-1-yl-ethanone derivatives. 192
Antitubercular activity of a new pyridinecarboxamidrazone compound alone and in combination with reference drugs, by MRA and in a macrophage model. 186
Exploring new structures in the development of new sigma ligands 184
3D pharmacophore model of σ1 binding site based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives. 180
Synthesis and antimycobacterial activity of (3,4-diaryl-3H-thiazol-2-ylidene)-hydrazide derivatives 178
Wet-dry-wet drug screen leads to the synthesis of TS1, a novel compound reversing lung fibrosis through inhibition of myofibroblast differentiation 176
1-substituted-3-(o-aminoalkyl)-1H-indole derivatives as possible sigma ligands. 173
PEGylation of coenzyme Q10 and in vitro release studies 173
2-Aryl-3-(1H-azol-1-yl)-1H-indole derivatives: a new class of antimycobacterial compounds. Convetional heating in comparison with MW-assisted synthesis. 171
null 168
Overview on σ1 receptor: a 3D homology model to solve a part of the enigma. 165
Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach. 165
Design, synthesis and biological profile of new piperidine-4-carboxamide as effective sigma ligands 154
3-Piperidin-4-yl-methyl-3H-benzoxazol-2-one derivatives as sigma ligands. 154
Synthesis and antimycobacterial activity of 1,3,4-oxadiazol-2-one derivatives 151
"Sintesi ed attività antimicobatterica di derivati 2-piridincarbossamidrazonici di 1-[4-(1H-imidazol-1-il)fenil]-3-arilpropanonni." 147
Design, synthesis and SAR analysis of novel selective sigma1 ligands (Part 2) 145
Antitubercular activity of novel 3-(2-oxo-2-arylethylidene)-3,4-dihydro-2H-benzo[b][1,4]oxazin-2-ones derivatives 145
Cytotoxicity Profiles and Neuroprotective Properties of the Novel Ifenprodil Analogues as Sigma Ligands 144
Benzoxazinones and correlated scaffolds linked to benzylamino moieties through a butylene spacer. New sigma receptor ligands 144
Synthesis and antimycobacterial activity of some 4H-1,2,4-triazin-5-one derivatives 143
Substituted benzylaminoalkylindoles with preference for the σ2 binding site 140
Iron Bioavailability in the Extracellular Environment Is More Relevant Than the Intracellular One in Viability and Gene Expression: A Lesson from Oligodendroglioma Cells 136
The sigma-enigma. A multistep homology modeling of sigma1 receptors 135
Progettazione e sintesi di nuovi derivati bis-imidazolici ad attività antifungina ed antimicobatterica 134
“Progettazione, sintesi e valutazione dell’attività antimicobatterica ed antifungina di nuovi derivati imidazolici e triazolici. Studio correlato di molecular modeling.” 133
Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands 131
SYNTHESIS, MOLECULAR MODELING AND EXPERIMENTALACTIVITY OF SOME NEW ACETAMIDE, BENZAMIDE ANDPHENYLMETHANONE DERIVATIVES AS SIGMA LIGANDS. 131
Molecular modeling in drug design. New chemicals with antibacterial, antitubercular and antifungal activity: synthesis and MIC evaluatiotn. Experimental and computational approach. 128
Synthesis and antimycobacterial activity of 5-aryl-1-isonicotynoyl-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrazole derivatives. 127
Enantioselective chromatography and absolute configuration of N,N-dimethyl-3-(naphthalen-2-yl)-butan-1-amines: potential sigma1 ligands. 127
A new class of substituted benzo[d]oxazole-2(3H)-one derivatives as sigma1 ligands. 127
Novel 1,4-Benzoxazin-3-One Derivatives as Potential Antitubercular Compounds Targeting MenB Enzyme 127
Benzossazol-2-oni e benzotiazol-2-oni come possibili ligandi sigma. 126
Hybridization approach to drug discovery inhibiting Mycobacterium tuberculosis. An overview 116
null 109
The sigma enigma. 3D homology modeling, computer-assisted drug design, 3D pharmacophore-guided docking, MM/PBSA scoring, in silico/in vitro alanine scanning mutagenesis, and functional assay to unveil the sigma-1 receptor hidden secrets. 104
null 103
null 101
New hybrid derivatives of 3,4-dihydroquinolin-2(1H)-one and 5-phenyl-1,3,4-oxadiazol-2(3H)-one scaffolds as sigma ligands 95
Synthesis, Antimycobacterial Activity, and Computational Insight of Novel 1,4‐Benzoxazin‐2‐one Derivatives as Promising Candidates against Multidrug‐Resistant Mycobacterium Tuberculosis 93
null 93
Synthesis, Biological Evaluation and Computational Studies of New Hydrazide Derivatives Containing 1,3,4-Oxadiazole as Antitubercular Agents 93
null 91
Discovery of first novel sigma/HDACi dual-ligands with a potent in vitro antiproliferative activity 88
null 88
null 88
Studio correlato a molecular modeling del’attività antifungina di nuovi derivati imidazolici e triazolici del piridincarbossamidrazone. 87
New hybrid derivatives of 3,4-dihydroquinolin-2(1H)-one and 5-phenyl-1,3,4-oxadiazol-2(3H)-one scaffolds as sigma-2 ligands 84
null 82
null 81
null 81
null 81
null 80
null 79
null 79
null 79
null 78
Synthesis and antifungal activity of new substituted 2-(1H-Imidazol-1-yl)-N-benzyl-N-(3-phenylprop-2-en-1-yl)-acetamide derivatives. 78
Orienting the design and synthesis towards sigma-2 receptor subtype 78
null 77
null 75
null 75
null 74
Design, synthesis and in vitro evaluation of antimycobacterial and antifungal activities of new heterocyclic derivatives 74
Synthesis, antifungal and antimycobacterial activities of new bis-imidazole derivatives. 74
null 73
null 73
“One-pot synthesis of a,b-unsatured caroxylic acids via tandem Wittig olefination-hydrolysis reaction under combined microwave and ultrasound irradiation”. 73
SAR evaluation of chiral naphtylorfines with antinociceptive activity. 73
Setup and Validation of a Reliable Docking Protocol for the Development of Neuroprotective Agents by Targeting the Sigma-1 Receptor (S1R) 73
null 72
null 72
SYNTHESIS AND ANTIMYCOBACTERIAL ACTIVITY OF 1,2,4-TRIAZOLINE-3-THIONE, 2,3-DIHYDROTHIAZOLE AND THIAZOLIDIN-4-ONE DERIVATIVES. 72
Totale 15.768
Categoria #
all - tutte 53.249
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.249


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.319 0 101 89 230 23 109 105 57 159 120 75 251
2022/20231.981 141 195 127 236 188 323 21 156 223 223 103 45
2023/20241.083 71 58 98 78 144 102 136 179 27 37 91 62
2024/20252.051 40 56 99 194 194 266 118 129 265 214 207 269
2025/20265.402 448 309 535 542 420 528 711 200 616 760 220 113
2026/2027215 172 43 0 0 0 0 0 0 0 0 0 0
Totale 18.685